Is CPRX undervalued or overvalued?

As of 2025-03-24, the Intrinsic Value of Catalyst Pharmaceuticals Inc (CPRX) is 37.25 USD. This CPRX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 24.23 USD, the upside of Catalyst Pharmaceuticals Inc is 53.80%. This means that CPRX is undervalued by 53.80%.

The range of the Intrinsic Value is 27.44 - 64.92 USD

	Range	Selected	Upside
a
DCF (Growth 5y)	27.44 - 64.92	37.25	53.8%
DCF (Growth 10y)	30.33 - 68.27	40.35	66.5%
DCF (EBITDA 5y)	26.71 - 36.64	31.84	31.4%
DCF (EBITDA 10y)	29.72 - 41.61	35.53	46.6%
Fair Value	33.74 - 33.74	33.74	39.23%
P/E	23.61 - 51.49	32.30	33.3%
EV/EBITDA	30.18 - 50.27	42.34	74.7%
EPV	17.99 - 23.87	20.93	-13.6%
DDM - Stable	8.66 - 28.03	18.35	-24.3%
DDM - Multi	9.59 - 25.90	14.21	-41.4%